Form 4: Indaptus Therapeutics Director Anthony Maddaluna Cancels Stock Options

Sentiment:

SEC Form 4


Director Anthony Maddaluna cancels stock options in Indaptus Therapeutics, receiving $500 in consideration.

Summary

  • Anthony Maddaluna, a director of Indaptus Therapeutics, Inc., filed a Form 4 indicating changes in beneficial ownership.
  • The filing reports the cancellation of several stock options by mutual agreement between Maddaluna and Indaptus Therapeutics.
  • Maddaluna received a total of $500 as consideration for the cancellation of these options.
  • The canceled options had exercise prices of $24.6, $388.64, and $355.2.
  • The options were originally granted on July 15, 2020, June 28, 2019, and June 28, 2018, and were exercisable for common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to insider transactions and provides insight into the compensation structure and holdings of company directors. It's common for directors to have stock options as part of their compensation, and cancellations can occur for various reasons, such as mutual agreement or changes in employment terms.

Stakeholder Impact

  • The cancellation of stock options and the $500 payment to the director could have a minor impact on the company's financials.

Key Dates

DateDescription
06/28/2018Grant date of one set of stock options.
06/28/2019Grant date of one set of stock options.
07/15/2020Grant date of one set of stock options.
06/28/2025Expiration date of one set of stock options.
07/15/2027Expiration date of one set of stock options.
04/10/2025Transaction date for the cancellation of stock options.
04/11/2025Date of signature for the Form 4 filing.

Keywords

Form 4, stock options, Indaptus Therapeutics, beneficial ownership, Maddaluna, INDP, director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.